Why Digital Transformation
Is your organization under pressure to improve discovery ROI? According to a 2014 report from the Tufts University Center for the Study of Drug Development, the average cost of going from chemical compound to FDA approved drug is $2.7B, and roughly only 1 in 1000 leads makes it to final approval. According to Nature Reviews, the average cost for lead optimization and preclinical in-vivo studies alone is over $0.5B per compound.
Small improvements in efficiency can save millions of dollars annually. In most cases, the need to improve efficiencies and…